Trader consensus heavily favors no new COVID variant of concern emerging before 2027, reflecting persistently low global circulation, stable surveillance data, and the absence of any lineage meeting WHO or ECDC criteria for elevated transmissibility, severity, or immune escape. As of mid-2026, monitored strains such as BA.3.2 (a variant under monitoring with notable spike mutations) and sublineages like XFG and NB.1.8.1 show increasing detections in some regions but remain classified below variant-of-interest or concern thresholds, with overall case rates, hospitalizations, and emergency visits staying very low. Recent wastewater and genomic trends indicate modest seasonal upticks without triggering reclassifications, while public health systems continue routine monitoring without signals of rapid evolution or policy impact. This environment makes designation of a new variant of concern unlikely in the short window remaining through 2026.